NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • March 15th, 2022 • IMARA Inc. • Pharmaceutical preparations • Pennsylvania
This Agreement is made and entered into as of May 27, 2021 (“Effective Date”), by and between the University of Pittsburgh – Of the Commonwealth System of Higher Education, a non-profit corporation, organized and existing under the laws of the Commonwealth of Pennsylvania, having an office at 1st Floor Gardner Steel Conference Center, 130 Thackeray Avenue, Pittsburgh, Pennsylvania 15260 (“University”), and Imara Inc. having its principal office at 116 Huntington Ave, Sixth Floor, Boston, MA 02116 (“Licensee”). University and Licensee each may be referred to herein individually as a “Party” or collectively as the “Parties.”
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 15th, 2022 • IMARA Inc. • Pharmaceutical preparations
This license agreement (this "Agreement") is made and is effective as of April 25, 2012 (the "Effective Date") between The UAB Research Foundation ("UABRF") and Complexa, Inc. (the "Licensee").
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 15th, 2022 • IMARA Inc. • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (the “Agreement”) is hereby entered into on October 19, 2020 (the “Effective Date”), by and between Complexa (assignment for the benefit of creditors), LLC, a Delaware limited liability company (in its sole and limited capacity as assignee for the benefit of creditors of Complexa, Inc., the “Seller”), with its principal office located at 3945 Freedom Circle, Suite 560, Santa Clara, California 95054, United States, and Imara Inc. (the “Buyer”), with its principal office located at 116 Huntington Ave, Sixth Floor, Boston, MA 02116, United States.
RSU AgreementRestricted Stock Unit Agreement • March 15th, 2022 • IMARA Inc. • Pharmaceutical preparations
This grant of RSUs satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
IMARA Inc. Boston, MA 02116 USA Info@Imaratx.comLetter Agreement • March 15th, 2022 • IMARA Inc. • Pharmaceutical preparations
Amendment No. 1 to Non-Exclusive License AgreementNon-Exclusive License Agreement • March 15th, 2022 • IMARA Inc. • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) is made as of December 8, 2021 (the “Amendment Effective Date”) by and between Imara Inc., a Delaware corporation having an address at 116 Huntington Avenue, 6th Floor, Boston, MA 02116 (“Licensee”) and the University of Pittsburgh – Of the Commonwealth System of Higher Education, a non-profit corporation, organized and existing under the laws of the Commonwealth of Pennsylvania, having an office at 1st Floor Gardner Steel Conference Center, 130 Thackeray Avenue, Pittsburgh Pennsylvania 15260 (“University”). Licensee and University may be referred to herein individually as a “Party” or collectively as the “Parties.”
